Nav: Home

PET/MR shows arterial CO2 as potent vasodilator for cardiac stress testing

June 05, 2017

RESTON, Va. -- More than 5 million cardiac stress tests performed annually in the U.S. employ injectable forms of pharmacological stress agents--such as adenosine or one of its analogues--to dilate blood vessels in the heart. However, these drugs can have severe side effects. Using PET/MR imaging, a new international study featured in the June issue of The Journal of Nuclear Medicine demonstrates that increases in partial pressure of arterial carbon dioxide (PaCO2) can safely and efficiently widen blood vessels of the heart during stress tests to help determine heart function.

Myocardial blood flow (MBF) is critical in determining heart function. While PaCO2's effect on MBF has been studied extensively in the past, previous findings have been inconclusive due to difficulty in quickly controlling PaCO2 to limit hypercapnia (too much carbon dioxide in the blood) and uncertain measures of the outcome variable. In this new study, these issues have been addressed.

"We have overcome these technical difficulties by incorporating new technology that can accurately, precisely and rapidly control arterial blood gas levels, and we have quantified the MBF response with 13N-ammonia PET, the gold standard approach for measuring MBF, in a clinically relevant animal model," explains Rohan Dharmakumar, PhD, of the Cedars-Sinai Medical Center and University of California, Los Angeles, California. "We report for the first time that a physiologically tolerable increase in PaCO2 (~25 mmHg) amplifies MBF more than two-fold, a key feature of clinically meaningful coronary vasodilators used for cardiac stress testing."

The study included three groups of canines: (1) without coronary stenosis, (2) with non-flow limiting stenosis and (3) pre-administered caffeine (which inhibits adenosine and can affect stress-test results). In all cases, PaCO2 proved just as effective at inducing MBF as the standard dose of adenosine and performs better than adenosine in animals pre-administered with caffeine.

"This key finding opens the door to a completely new protocol for cardiac stress testing--one that has the potential to benefit numerous patients who are contraindicated for commonly used pharmacological stress agents," says Dharmakumar. "Since hypercapnia is safe and effective when its magnitude is tightly controlled, it could also empower repeat stress testing in target populations with heart disease--overcoming a limitation of current stress tests that rely on injectable pharmacological agents."
-end-
The authors of "Arterial CO2 as a Potent Coronary Vasodilator: A Preclinical PET/MR Validation Study with Implications for Cardiac Stress Testing" include Hsin-Jung Yang, Damini Dey, Avinash Kali, Roya Yumul, Debiao Li, Piotr J. Slomka, Daniel S. Berman, and Rohan Dharmakumar, Cedars-Sinai Medical Center and University of California, Los Angeles, California; Jane Sykes, John Butler, Michael S. Kovacs, and Frank S. Prato, University of Western Ontario, London, Canada; Michael Klein, Olivia Sobczyk, and Joseph A. Fisher, University of Toronto, Toronto, Canada; Behzad Sharif, Ivan Cokic, Richard Tang, Antonio H. Conte, and Mourad Tighiouart, Cedars-Sinai Medical Center; Xiaoming Bi, Siemens Healthcare, Los Angeles, California; and Sotirios A. Tsaftaris, University of Edinburgh, Edinburg, UK.

This work was supported in part by a grant from the National Heart, Lung and Blood Institute at NIH (HL091989).

Please visit the SNMMI Media Center to view the PDF of the study, including images, and more information about molecular imaging and personalized medicine. To schedule an interview with the researchers, please contact Laurie Callahan at (703) 652-6773 or lcallahan@snmmi.org. Current and past issues of The Journal of Nuclear Medicine can be found online at http://jnm.snmjournals.org.

About the Society of Nuclear Medicine and Molecular Imaging

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to raising public awareness about nuclear medicine and molecular imaging, a vital element of today's medical practice that adds an additional dimension to diagnosis, changing the way common and devastating diseases are understood and treated and helping provide patients with the best health care possible.

SNMMI's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit http://www.snmmi.org.

Society of Nuclear Medicine

Related Adenosine Articles:

Discovery of tanycytic TSPO inhibition as a potential therapeutic target for obesity treatment
Professor Eun-Kyoung Kim's team in the Department of Brain and Cognitive Sciences discovered the mechanism underlying the regulation of energy metabolism by hypothalamic tanycyte.
New pharmaceutical target reverses osteoporosis in mice
Biomedical engineers at Duke University have discovered that an adenosine receptor called A2B can be pharmaceutically activated to reverse bone degradation caused by osteoporosis in mouse models of the disease.
New target found for disease of the heart's smallest blood vessels
When we race walk, for example, part of our healthy heart muscle may want a little more blood and oxygen, so our tiniest blood vessels send a message upstream to the larger vessels to send more.
The circadian-hypoxia link in cardioprotection
Throughout the evolutionary time, all organisms and species on Earth evolved with an adaptation to consistent oscillations of sunlight and darkness, now recognized as circadian rhythm.
Impeding white blood cells in antiphospholipid syndrome reduced blood clots
A new study examined APS at the cellular level and found that two drugs reduced development of blood clots in mice affected with the condition.
More Adenosine News and Adenosine Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...